Skip to main content

Advertisement

Log in

Whole-body MRI vs bone scintigraphy in the staging of Ewing sarcoma of bone: a 12-year single-institution review

  • Musculoskeletal
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

Objective

To compare whole-body MRI (WB-MRI) at 1.5/3T and bone scintigraphy in the skeletal staging of Ewing sarcoma (ES) of bone.

Methods

All patients with a histological diagnosis of ES of bone between 2007 and 2018 were retrospectively reviewed. The analysis included gender, mean age, skeletal distribution, and prevalence of skeletal metastases on WB-MRI and bone scintigraphy.

Results

The study group comprised 182 patients with a mean age of 18.0 years (range 2–56 years), 126 males and 56 females. Skeletal metastases were detected overall in 30 patients (16.5%), in 23 of 96 patients (24%) who underwent WB-MRI, and in 20 of 118 patients (16.9%) who underwent bone scintigraphy. Of 71 patients who underwent both WB-MRI and bone scintigraphy, skeletal metastases were detected on both modalities in 13 (18.3%), while in 4 patients, skeletal metastases were identified on WB-MRI alone. There were no patients in whom skeletal metastases were identified on bone scintigraphy alone. Of 13 patients with skeletal metastases who underwent both studies, WB-MRI showed a greater number of metastatic foci in 10 (76.9%). However, scintigraphy was superior to WB-MRI in detecting skull vault lesions, but did show false-positive results around the long bone growth plates.

Conclusion

WB-MRI is more sensitive than bone scintigraphy in detecting skeletal metastases in ES of bone, with the exception of skull vault metastases. Consideration should be given to replacing bone scintigraphy with WB-MRI.

Key Points

• Whole-body MRI is more sensitive than bone scintigraphy in detecting skeletal metastases in Ewing sarcoma of bone.

• Whole-body MRI can safely replace bone scintigraphy for staging of the skeleton, with the acknowledgement of the possibility of missing a clinically occult skull vault metastasis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Abbreviations

ES:

Ewing sarcoma

OS:

Osteosarcoma

WB-MRI:

Whole-body MRI

References

  1. Arndt CAS, Rose PS, Folpe AL, Laack NN (2012) Common musculoskeletal tumors of childhood and adolescence. Mayo Clin Proc 87:475–487

    Article  PubMed  PubMed Central  Google Scholar 

  2. Gorlick R, Janeway K, Lessnick S, Randall RL, Marina N (2013) Children’s oncology group’s 2013 blueprint for research: bone tumors. Pediatr Blood Cancer 60:1009–1015

  3. Murphey MD, Senchak LT, Mambalam PK et al (2013) From the radiologic pathology archives: Ewing sarcoma family of tumors: radiologic-pathologic correlation. Radiographics 33:803–831

    Article  PubMed  Google Scholar 

  4. Gerrand C, Athanasou N, Brennan B et al (2016) UK guidelines for the management of bone sarcomas. Clin Sarcoma Res 6:7

    Article  PubMed  PubMed Central  Google Scholar 

  5. Casali PG, Bielack S, Abecassis N et al (2018) Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 29:iv79–iv95

    Article  CAS  PubMed  Google Scholar 

  6. Hattori T, Yamakawa H, Nakayama N et al (1999) Skull metastasis of Ewing’s sarcoma--three case reports. Neurol Med Chir (Tokyo) 39:946–949

    Article  CAS  Google Scholar 

  7. Daldrup-Link HE, Franzius C, Link TM et al (2001) Whole-body MR imaging for detection of bone metastases in children and young adults: comparison with skeletal scintigraphy and FDG PET. AJR Am J Roentgenol 177:229–236

    Article  CAS  PubMed  Google Scholar 

  8. Kumar J, Seith A, Kumar A et al (2008) Whole-body MR imaging with the use of parallel imaging for detection of skeletal metastases in pediatric patients with small-cell neoplasms: comparison with skeletal scintigraphy and FDG PET/CT. Pediatr Radiol 38:953–962

    Article  PubMed  Google Scholar 

  9. Costelloe CM, Madewell JE, Kundra V, Harrell RK, Bassett RL Jr, Ma J (2013) Conspicuity of bone metastases on fast Dixon-based multisequence whole-body MRI: clinical utility per sequence. Magn Reson Imaging 31:669–675

  10. Rana K, Wadhwa V, Bhargava EK, Batra V, Mandal S (2015) Ewing’s sarcoma multifocal metastases to temporal and occipital bone: a rare presentation. J Clin Diagn Res 9:MD04–MD05

  11. Rager O, Nkoulou R, Exquis N et al (2017) Whole-body SPECT/CT versus planar bone scan with targeted SPECT/CT for metastatic workup. Biomed Res Int 2017:7039406–7039408

    Article  PubMed  PubMed Central  Google Scholar 

  12. Vanel D (2004) MRI of bone metastases: the choice of the sequence. Cancer Imaging 4:30–35

    Article  PubMed  PubMed Central  Google Scholar 

  13. O’Sullivan GJ, Carty FL, Cronin CG (2015) Imaging of bone metastasis: an update. World J Radiol 7:202–211

    Article  PubMed  PubMed Central  Google Scholar 

  14. Vanel D, Casadei R, Alberghini M, Razgallah M, Busacca M, Albisinni U (2009) MR imaging of bone metastases and choice of sequence: spin echo, in-phase gradient echo, diffusion, and contrast medium. Semin Musculoskelet Radiol 13:97–103

  15. Cotterill SJ, Ahrens S, Paulussen M et al (2000) Prognostic factors in Ewing’s tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing’s Sarcoma Study Group. J Clin Oncol 18:3108–3114

    Article  CAS  PubMed  Google Scholar 

  16. Hargaden G, O'Connell M, Kavanagh E, Powell T, Ward R, Eustace S (2003) Current concepts in whole-body imaging using turbo short tau inversion recovery MR imaging. AJR Am J Roentgenol 180:247–252

  17. Smets AM, Deurloo EE, Slager TJE, Stoker J, Bipat S (2018) Whole-body magnetic resonance imaging for detection of skeletal metastases in children and young people with primary solid tumors - systematic review. Pediatr Radiol 48:241–252

  18. Eustace S, Tello R, DeCarvalho V et al (1997) A comparison of whole-body turboSTIR MR imaging and planar 99mTc-methylene diphosphonate scintigraphy in the examination of patients with suspected skeletal metastases. AJR Am J Roentgenol 169:1655–1661

    Article  CAS  PubMed  Google Scholar 

  19. Gosfield E 3rd, Alavi A, Kneeland B (1993) Comparison of radionuclide bone scans and magnetic resonance imaging in detecting spinal metastases. J Nucl Med 34:2191–2198

  20. Avrahami E, Tadmor R, Dally O, Hadar H (1989) Early MR demonstration of spinal metastases in patients with normal radiographs and CT and radionuclide bone scans. J Comput Assist Tomogr 13:598–602

    Article  CAS  PubMed  Google Scholar 

  21. Flickinger FW, Sanal SM (1994) Bone marrow MRI: techniques and accuracy for detecting breast cancer metastases. Magn Reson Imaging 12:829–835

    Article  CAS  PubMed  Google Scholar 

  22. Siegel MJ, Acharyya S, Hoffer FA et al (2013) Whole-body MR imaging for staging of malignant tumors in pediatric patients: results of the American College of Radiology Imaging Network 6660 Trial. Radiology 266:599–609

    Article  PubMed  PubMed Central  Google Scholar 

  23. Goo HW, Choi SH, Ghim T, Moon HN, Seo JJ (2005) Whole-body MRI of paediatric malignant tumours: comparison with conventional oncological imaging methods. Pediatr Radiol 35:766–773

  24. Mazumdar A, Siegel MJ, Narra V, Luchtman-Jones L (2002) Whole-body fast inversion recovery MR imaging of small cell neoplasms in pediatric patients: a pilot study. AJR Am J Roentgenol 179:1261–1266

    Article  PubMed  Google Scholar 

  25. Kellenberger CJ, Miller SF, Khan M, Gilday DL, Weitzman S, Babyn PS (2004) Initial experience with FSE STIR whole-body MR imaging for staging lymphoma in children. Eur Radiol 14:1829–1841

  26. Quartuccio N, Fox J, Kuk D et al (2015) Pediatric bone sarcoma: diagnostic performance of 18F-FDG PET/CT versus conventional imaging for initial staging and follow-up. AJR Am J Roentgenol 204:153–160

    Article  PubMed  Google Scholar 

  27. Ulaner GA, Magnan H, Healey JH, Weber WA, Meyers PA (2014) Is methylene diphosphonate bone scan necessary for initial staging of Ewing sarcoma if 18F-FDG PET/CT is performed? AJR Am J Roentgenol 202:859–867

  28. London K, Stege C, Cross S et al (2012) 18F-FDG PET/CT compared to conventional imaging modalities in pediatric primary bone tumors. Pediatr Radiol 42:418–430

    Article  PubMed  Google Scholar 

  29. Palmerini E, Colangeli M, Nanni C et al (2017) The role of FDG PET/CT in patients treated with neoadjuvant chemotherapy for localized bone sarcomas. Eur J Nucl Med Mol Imaging 44:215–223

    Article  CAS  PubMed  Google Scholar 

  30. Huang B, Law MW, Khong PL (2009) Whole-body PET/CT scanning: estimation of radiation dose and cancer risk. Radiology 251:166–174

    Article  PubMed  Google Scholar 

  31. Willowson KP, Bailey EA, Bailey DL (2012) A retrospective evaluation of radiation dose associated with low dose FDG protocols in whole-body PET/CT. Australas Phys Eng Sci Med 35:49–53

    Article  PubMed  Google Scholar 

  32. Purz S, Sabri O, Viehweger A et al (2014) Potential pediatric applications of PET/MR. J Nucl Med 55:32S–39S

    Article  CAS  PubMed  Google Scholar 

  33. Daldrup-Link H (2017) How PET/MR can add value for children with cancer. Curr Radiol Rep 5:15–39

    Article  PubMed  PubMed Central  Google Scholar 

  34. Lee YZ, Oldan JD, Fordham LA (2017) Pediatric applications of hybrid PET/MR imaging. Magn Reson Imaging Clin N Am 25:367–375

    Article  PubMed  Google Scholar 

  35. Stecco A, Trisoglio A, Soligo E, Berardo S, Sukhovei L, Carriero A (2018) Whole-body MRI with diffusion-weighted imaging in bone metastases: a narrative review. Diagnostics (Basel) 8:45–56

  36. Puerta P, Guillén A, Mora J, Suñol M, Ferrer E (2015) Isolated skull metastasis of Ewing’s sarcoma in a child. Austin J Cancer Clin Res 2:1–3

  37. Asif N, Khan AQ, Siddiqui YS, Mustafa H (2010) Metastasis from scapular Ewing’s sarcoma presenting as sutural diastasis: an unusual presentation. Int J Shoulder Surg 4:18–21

    Article  PubMed  PubMed Central  Google Scholar 

  38. Biswas B, Bakhshi S (2016) Management of Ewing sarcoma family of tumors: current scenario and unmet need. World J Orthop 7:527–538

    Article  PubMed  PubMed Central  Google Scholar 

  39. Ozaki T (2015) Diagnosis and treatment of Ewing sarcoma of the bone: a review article. J Orthop Sci 20:250–263

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Funding

The authors state that this work has not received any funding.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sarah Kalus.

Ethics declarations

Guarantor

The scientific guarantor of this publication is Dr. Asif Saifuddin.

Conflict of interest

The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.

Statistics and biometry

No complex statistical methods were necessary for this paper.

Informed consent

Written informed consent was waived by the Institutional Review Board.

Ethical approval

Institutional Review Board approval was obtained.

Methodology

• retrospective

• diagnostic study

• performed at one institution

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kalus, S., Saifuddin, A. Whole-body MRI vs bone scintigraphy in the staging of Ewing sarcoma of bone: a 12-year single-institution review. Eur Radiol 29, 5700–5708 (2019). https://doi.org/10.1007/s00330-019-06132-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-019-06132-9

Keywords

Navigation